Jiangsu gdk Biotechnology Co Ltd
688670
Company Profile
Business description
Jiangsu gdk Biotechnology Co Ltd is a biological high-tech enterprise integrating scientific research, production, operation and service of human vaccines. The company's product pipeline covers prevention of five important infectious diseases such as influenza, rabies, chickenpox, shingles and pneumonia.
Contact
No. 12 Yujin Road
Jiangsu Province
Taizhou225300
CHNT: +86 52386205860
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
452
Stocks News & Analysis
stocks
Our three most overvalued ASX shares
These three companies are trading at a significant premium to our fair value.
stocks
What does big US court decision mean for Google’s parent company Alphabet?
Alphabet shares popped 7% after the ruling on September 2 and have now rallied by around 50% since April.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,115.70 | 13.70 | -0.15% |
| CAC 40 | 7,674.78 | 24.14 | -0.31% |
| DAX 40 | 23,596.98 | 173.35 | -0.73% |
| Dow JONES (US) | 45,400.86 | 220.43 | -0.48% |
| FTSE 100 | 9,208.21 | 8.66 | -0.09% |
| HKSE | 25,508.17 | 90.19 | 0.35% |
| NASDAQ | 21,700.39 | 7.30 | -0.03% |
| Nikkei 225 | 43,555.43 | 536.68 | 1.25% |
| NZX 50 Index | 13,263.18 | 39.65 | 0.30% |
| S&P 500 | 6,481.50 | 20.58 | -0.32% |
| S&P/ASX 200 | 8,839.80 | 15.40 | -0.17% |
| SSE Composite Index | 3,818.82 | 6.31 | 0.17% |